Domain Not Resolving

Organization Schema

Person Schema

CrUX Dataset

CrUX Top 50m

Microsoft

Microsoft Azure

Microsoft Azure US South Region

Chief Executive Officer

Renato Skerlj

VP Computational Chemistry

Andrew Good

Finance and Administration

Jennifer Visco, CPA

Senior Vice President, Drug Discovery

Mark Ledeboer

Senior Vice President, Business Development

Sudhir Rao

SVP of Research

Valerie Cullen

Senior Director Structural Biology

Peter Connolly

Associate Director, Operations

Sandra Kairyte

Director

Suzanne Rzuczek

Associate Director Project Management

Tiviane Vu

Beth Seidenberg

Campbell Murray

Yujiro S. Hata

Matthew D. Disney

Kevin Forrest

Eric Wang

Jason P. Hafler

Scott M. Rocklage

Scientific Founder

Brian Daniels

SVP of Business Development

Senior Vice President, Research

Jason Ruth

Principal

United States Companies With Less Than $1B in Revenue (Top 10K)

Western US Companies With Fewer Than 100 Employees (Top 10K)

Health Care Companies With Less Than $500M in Revenue (Top 10K)

Health Care Companies With Fewer Than 1000 Employees (Top 10K)

Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases.


Venture Round - Expansion Therapeutics

Cormorant Asset Management

Series B - Expansion Therapeutics

5AM Ventures

Kleiner Perkins

Series A - Expansion Therapeutics

San Diego

California

United States

North America

Expansion Therapeutics

Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development

The Week’s Biggest Funding Rounds: Faux Cheese, Hunting Tech Talent, And Insurance Policies Against Hackers

Expansion Therapeutics Widens Funding by $80 Million for RNA-Linked Research

Life Sciences: A Data-Driven Diagnosis For Success

A platform that identifies druggable RNA structures to develop oral medicines for RNA-mediated diseases.

A program targeting tau protein imbalances to treat dementias and movement disorders by altering tau splicing patterns.

A program addressing ALS and frontotemporal dementia by targeting the C9orf72 mRNA to prevent toxic polypeptide formation.

A program targeting r(CUG) repeat expansions in the DMPK gene to restore normal pre-mRNA splicing and protein production.

A tool that uses small molecules to tag RNA targets with a purification tag for identification.

A tool that cleaves RNA targets in cells to assess target engagement transcriptome-wide.

Bangladesh

Asia

Mexico

HTML5

Google Analytics

GoDaddy Premium DNS

Modernizr

Wordpress

Microsoft Outlook

Google Fonts

Google Tag Manager

Matomo (Formerly Piwik)

Google Compute Engine

Expansion Therapeutics is a drug discovery and development company focused on pursuing the potential of small molecule medicines for RNA-mediated diseases. The company has significantly expanded on scientific founder Matt Disney’s breakthrough work in addressing Small Molecules interacting with RNA (SMiRNA) for major neurological diseases.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 10:56 AM	be1b48c1
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 10:56 AM	4a91e18c
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	44b0954b
crunchbase profile	general	Nov 22, 2024 9:33 AM	10c63257
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 2:03 PM	bbe9338e
peers	general
news basic	general	Mar 8, 2024 10:56 AM	a7caac6c
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

EXPA

COM:EXPANSIONRX

Expansion Therapeutics